Hologic Cash Conversion Cycle from 2010 to 2025

HOLX Stock  USD 62.32  0.84  1.37%   
Hologic Cash Conversion Cycle yearly trend continues to be fairly stable with very little volatility. Cash Conversion Cycle is likely to outpace its year average in 2025. During the period from 2010 to 2025, Hologic Cash Conversion Cycle regression line of annual values had r-squared of  0.60 and arithmetic mean of  123.88. View All Fundamentals
 
Cash Conversion Cycle  
First Reported
2010-12-31
Previous Quarter
139.08739595
Current Value
169.21
Quarterly Volatility
24.96965615
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Hologic financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Hologic's main balance sheet or income statement drivers, such as Depreciation And Amortization of 373.1 M, Interest Expense of 74.8 M or Total Revenue of 4.9 B, as well as many indicators such as Price To Sales Ratio of 2.14, Dividend Yield of 0.0 or PTB Ratio of 3.24. Hologic financial statements analysis is a perfect complement when working with Hologic Valuation or Volatility modules.
  
Check out the analysis of Hologic Correlation against competitors.
For more information on how to buy Hologic Stock please use our How to Invest in Hologic guide.

Latest Hologic's Cash Conversion Cycle Growth Pattern

Below is the plot of the Cash Conversion Cycle of Hologic over the last few years. It is Hologic's Cash Conversion Cycle historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Hologic's overall financial position and show how it may be relating to other accounts over time.
Cash Conversion Cycle10 Years Trend
Slightly volatile
   Cash Conversion Cycle   
       Timeline  

Hologic Cash Conversion Cycle Regression Statistics

Arithmetic Mean123.88
Geometric Mean121.41
Coefficient Of Variation20.16
Mean Deviation20.26
Median129.71
Standard Deviation24.97
Sample Variance623.48
Range77.7411
R-Value0.77
Mean Square Error270.40
R-Squared0.60
Significance0.0005
Slope4.05
Total Sum of Squares9,352

Hologic Cash Conversion Cycle History

2025 169.21
2024 139.09
2022 150.76
2016 129.71
2011 91.47
2010 136.7

About Hologic Financial Statements

Hologic investors use historical fundamental indicators, such as Hologic's Cash Conversion Cycle, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Hologic. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Cash Conversion Cycle 139.09  169.21 

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Hologic Stock Analysis

When running Hologic's price analysis, check to measure Hologic's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Hologic is operating at the current time. Most of Hologic's value examination focuses on studying past and present price action to predict the probability of Hologic's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Hologic's price. Additionally, you may evaluate how the addition of Hologic to your portfolios can decrease your overall portfolio volatility.